,

Dr. Claude Thibeault, Medical Advisor, IATA

After graduating from Sherbrooke University, Dr Claude Thibeault began his practice in the Canadian Armed Forces, where he specialized in Aerospace Medicine and Occupational Health. He then worked as Deputy Director of Civil Aviation Medicine in Ottawa before he joined Air Canada. Dr Thibeault retired as Air Canada Medical Director to become a consultant in Aerospace Medicine. He is President of Consultants Aeromed Inc. and is the Medical Advisor of IATA.

Dr Thibeault has been and still is very active in Aerospace Medicine. He has published several articles including a chapter in the last edition of Fundamentals of Aerospace Medicine textbook and another one in Occupational Health Medicine: State of the Art Review. He has delivered more than 140 conferences on various subjects related to Aerospace Medicine and Occupational Health.

Dr Thibeault is the Past President of the Aerospace Medical Association, the International Academy of Aviation and Space Medicine, the Airline Medical Directors Association and the Canadian Aerospace and Aeromedical Transport Association. He is the current Secretary General of the International Academy of Aviation and Space medicine. In 2007 he received the AsMA Won Chuel Kay Award for Outstanding Achievement in international aviation medicine and in 2012 he received the Louis H.Bauer Founder Award for the most significant contribution in aerospace medicine.

Dr. Anthony Evans, Chief, Aviation Medicine Section, ICAO

Since 2005, Dr. Evans is Chief, Aviation Medicine Section at the International Civil Aviation Organization in Montreal. From 1987 to 2005, Dr. Evans worked at the UK CAA first as medical officer and eventually became CMO. He has obtained ATPL and flew part-time as a pilot for a number of airlines on several aircraft types, including the B757 and 767.

Dr. Annette Ruge, Chief Medical Officer, EASA

Dr Annette Ruge is the Chief Medical Officer in the European Aviation Safety Agency and her main responsibility is the drafting and updating medical rules for pilots, cabin crew and air traffic controllers.

Dr Ruge completed her medical studies at the Justus-Liebig-University in Giessen, Germany, and then specialised in intensive care.

Dr Ruge has worked in aviation medicine since 1994 when she joined the German "Luftfahrt Bundesamt" in Braunschweig, Germany as a Medical Officer.

In 1999 the LBA seconded Dr Ruge to the Central JAA in Hoofddorp, Netherlands, where she was in charge of coordinating the drafting of and amendments to JAR-FCL 3 (Medical) and JAR-FCL 4 (Flight Engineers) as well as for Standardisation activities after implementation of the JARs in the field of pilot licensing in the same year.

She moved on to the CAA UK (Gatwick, United Kingdom) in 2003 as Head of the newly founded Aviation Health Unit. Dr Ruge joined the European Aviation Safety Agency (EASA) in 2007 and works closely together with European Member States, Industry and the European Commission towards uniform rules for the aero-medical examination and assessment of air crew and air traffic controllers in Europe.

Dr. Robert Johnson, CAMI Deputy Director, FAA, USA

Dr. Johnson is the Deputy Director of the FAA Civil Aerospace Medical Institute in Oklahoma City, Oklahoma. Prior to his current position he was an Associate Professor at the University of Texas Medical Branch where he was the, Associate Director of the UTMB/NASA-Johnson Space Center Aerospace Medicine Residency Program, and the Course Director of the Introduction to Aerospace Medicine Residency short course.

Dr Johnson retired from the U.S. Air Force in 2005. His assignments included 4 years of Chief Evaluation at the aviation medicine consultation service at the USAF School of Aviation Medicine. Dr. Johnson is board certified by the American Board of Preventive Medicine in Aerospace Medicine. He is a Fellow of the American College of Preventive Medicine, a Fellow of the Aerospace Medical Association, an Academician in the International Academy of Aviation and Space Medicine and a past President of the American Society of Aerospace Medical Specialists.

Dr. Johnson has published numerous articles on flight safety and aerospace medicine. He is the co-editor of the textbook “Fundamentals of Aerospace Medicine, 4th ed.” and he serves as an Aerospace Medicine representative on the ACGME Preventive Medicine Residency Review Committee and the current Chairperson of that committee. Throughout his career, Dr. Johnson has been closely involved with the medical aspects of Aerospace Medicine in both the civilian and federal government sectors.

Richard Fox, Honeywell

Dr. Richard Fox, an Engineer Fellow within the Honeywell Aerospace Advanced Technology Organization, has been an active participant in the development of SAE and ASHRAE Aerospace Standards for Aircraft Bleed and Cabin Air Quality for 23 years. Richard chaired the SAE E-31 committee on emissions measurement in the mid 1990’s and sponsored the first SAE Bleed Air Measurement Recommended Practice ARP 4418, which was first published in 1995. He actively participated in drafting a number of related SAE Aerospace Information Reports and Recommended Practices related to environmental control system chemical and particulate contaminants.

He is the longest serving member on the ASHRAE SPC161 Standard Committee, having been an active participant since its inception in 1994. Dr. Fox received his PhD in 2012, and published a dissertation “Assessing aircraft supply air to recommend compounds for timely warning of contamination” relevant to the needs of the industry related to bleed air contaminant measurement. His 26 years of experience in testing aircraft bleed air purity and consulting to the industry will be useful in leading a panel to develop a new SAE Bleed Air Purity Standard entitled “Bleed Air Contamination Limits for Safety, Health, and Comfort of Aircraft Occupants.”

Dr. Willem (Pim) A. Godefroy, Passe Partout Training

Pim is an international expert in providing services for disabled people and people with reduced mobility (PRMs) in the field of aviation. Trained originally as a clinical psychologist and specialist in rehabilitation psychology and neuropsychology, he has worked in this field for over ten years. He set up his own company IHD in 1988 initially to provide a range of activities to support the travel needs of disabled people. IHD developed into a highly specialized company focused entirely on PRM assistance at airports. His company has provided assistance over twenty years to large numbers of disabled travellers passing through Amsterdam and Brussels airports. Pim now draws on this in-depth operational experience to lead IHD Consultancy which is working with airports across Europe to ensure that their policies and practices deliver best practice in meeting the needs of disabled people and PRMs and that they comply with EC Regulation 1107/2006 as well as other relevant European and US requirements and best practice.

Besides his activities as a consultant he is a trainer on PRM issues in PassePartout Training Ltd., providing training for staff of PRM assistance providers and for other staff working at airports, as well as training for airline staff. Airports in which he is currently working include Abu Dhabi, Pafos, Larnaca, Brussels South, Paris CDG and Riga. He is also working for international organisations including ACI Global Training Hub. In addition, he has been an expert advisor to the European Civil Aviation Conference (ECAC) sub-group on PRMs for over ten years. Pim is fluent in English, French and German as well as his native Dutch.

Dr Richard Brown, WHO

Richard Brown is a Technical Officer with the Chemical Safety Team at the WHO, and is responsible for the development of the WHO Human Health Risk Assessment Model for Insecticides used in Aircraft Disinsection. Dr Brown has a background in human health risk assessment of chemicals in a variety of occupational and regulatory settings.

Prof. Michael Bagshaw, Associate Consultant, BRE, UK

Michael Bagshaw is Visiting Professor of Aviation Medicine at King’s College London and visiting Professor at Cranfield University.

Previously Head of Medical Services at British Airways, prior to which he was a Consultant in Neuro-otology at St George’s Hospital, London, and a General Practitioner.

This followed a career in the Royal Air Force as a medical officer, flying instructor and test pilot. He holds an Airline Transport Pilot licence and is a flight instructor and examiner.

Dr. Pooshan Navathe, Principal Medical Officer,CASA, Australia

Paul Morell, VP, Safety & Regulatory Compliance, US Airways

Captain Paul Morell, US Airways vice president, safety and regulatory compliance, serves as the airline’s Federal Aviation Administration (FAA)-mandated director of safety, ensuring that required safety program elements have been established, implemented, and maintained throughout the airline. He oversees flight, inflight, maintenance, ground and employee safety programs environmental programs, emergency planning and response, operations security, internal evaluation program and US Airways Safety Management System (SMS).

Morell’s other leadership responsibilities include chairman of the Airlines for America Safety Council, and industry co-chair of the Aviation Safety Information Analysis & Sharing (ASIAS) Executive Board.

Morell is an aviation veteran, previously serving as US Airways’ director, flight training and standards. He was also fleet captain for the US Airways’ Airbus A330, Boeing 757 and Boeing 767 fleets, overseeing pilot training and operational policies and procedures. Prior to joining US Airways, Morell was a US Navy fighter pilot and aviation safety officer, where he managed a program of maintenance and aviation safety training and awareness during the fleet introduction of the F-14 aircraft. Morell has 43 years of aviation experience. Morell holds a master’s degree in business administration from National University in San Diego and a bachelor’s degree in civil engineering from the Illinois Institute of Technology.

Dr.Clement Furlong, University of Washington

Dr. Furlong received a B.A. in Chemistry from San Jose State College in 1963 and a Ph.D. in Biochemistry from the University of California, Davis in 1968. He then spent two postdoctoral years at Cornell University, Ithaca, N.Y. working on bacterial ABC transporters. He continued this research as a faculty member in the Biochemistry Department at the University of California, Riverside. In 1976 he spent a sabbatical at Stanford University working with Drs. Harden McConnell and Hugh McDevitt studying immunology. In 1977, Dr. Furlong joined the Departments of Medicine (Division of Medical Genetics) and Genetics (now Genome Sciences) at the University of Washington where he has worked on gene-environment interactions and the development of surface plasmon resonance (SPR) biosensors.

One main area of research is the genetic variability of sensitivity to organophosphorus compounds. He and his research team isolated, sequenced and characterized the human paraoxonase 1 (PON1) gene and encoded protein and expressed recombinant active PON1 in E. coli. Further research with genetically engineered strains of mice demonstrated the importance of this protein in determining resistance to the common insecticides diazinon and chlorpyrifos. Low PON1 levels have also been demonstrated to be a risk factor for carotid artery disease. Recent experiments in other laboratories have demonstrated the importance of PON1 in the inactivation of microbial quorum sensing factors and inhibition of biofilm formation. Some evidence suggests that PON1, via its role in modulating oxidative stress, may be involved in neurological diseases. As a component of the HDL particles, PON1 may serve as a sensitive biomarker for defects in the modulation of oxidative stress, a fundamental problem in Parkinson disease. Other recent efforts have focused on identifying biomarkers of exposure to tricresyl phosphate, a component of jet engine lubricants. An extension of this research has focused on characterizing safer anti-wear tri-aryl phosphate lubricant additives.

Dr. Richard Pleus, Intertox

RICHARD C. PLEUS, PHD, Intertox managing director and toxicologist, is an expert in neurological and reproductive toxicology with over 25 years’ experience assessing the risk to humans exposed to chemical and biological agents via food, consumer products, therapeutic agents, and the environment.

Dr. Pleus has served on a number of expert panels for a number of toxicology-related matters. He is a member of the US delegation to the International Organization for Standardization and a delegate for the US-Russian Bilateral Presidential Commission on Science and Technology for environmental toxicology matters.

Dr. Pleus is the founder and Managing Director of Intertox, Inc., an independent scientific consulting and research organization. Dr. Pleus is also co-founder and Chief Scientist of Intertox Decision Sciences, LLC, a risk-management company offering software and database solutions for several industries. His credentials include a BS in Physiology, with honors, from Michigan State University; an MS in Environmental Health and a PhD in Environmental Toxicology from the University of Minnesota; and postdoctoral research in neuropharmacology at the University of Nebraska Medical Center.

Karen Bull, Pall Corporation

Professional Qualifications
Southampton University - B.Eng. (Hons) in Aeronautics and Astronautics.
As part of the university degree course, completed a 4 year engineering sponsorship with BAE Systems, Space and Communications Division.

Work Experience
22 years experience with Pall Aerospace in a variety of departments, including 17 years in sales and marketing. Member of the ASHRAE aviation sub committee, SSPC161, which has recently published the standard 161 “Air Quality within commercial Aircraft”.

Gave her first presentation on aircraft cabin air systems in 1994 and has been involved on the subject ever since. Pall has been a project member of a number of EC projects focusing on aircraft cabin air quality including; ASICA, CabinAir, FACE and iSPACE and continues to be at the forefront of aircraft cabin air developments.

Dr. Jerome Hogsette, USDA

Jerome Hogsette is a Research Entomologist and Lead Scientist at the USDA in Gainesville, Florida, USA. His specialty is biology, ecology and management of nuisance flies, especially the House Fly, Musca domestica, and the Stable Fly, Stomoxys calcitrans. Besides working nationally and internationally on agricultural and urban projects, since 2001 he has led the project to disinsect commercial aircraft without the use of pesticides. Dr. Hogsette has Adjunct Professor status at the University of Florida, Gainesville, Florida, and Montana State University, Bozeman, Montana. He has been an invited speaker at numerous professional and educational meetings, mentored 30 graduate students and written 170 scientific publications, book chapters, extension publications and articles in the popular press.

Dr. Tim Sprott Medical Director, Air New Zealand

Tim has worked for Air NZ since 1999 and has been CMO since March 2009. In his spare time he enjoys sailing, and when he can mucking around in R44s and Cessna 152 with his daughter and son, who are commercial pilots. His son is still trying to scare the xxxx out of him with aerobatics.

Dr. SanJe Cho, Korean Air AME

Dr. Cho, born in Dec. 5st, 1977, was educated at Medical College of University of Ulsan, has experience in family medicine for 3 years at ASAN medical center.

Dr. Cho has joined Korean Air to lead her career in aviation medicine with enthusiasm since 2008.

Dr. Cho does physical examination for Korean Air employees including pilots, cabin crews.

Dr. Cho designated AME for FAA in 2011.

Dr. Paulo M. Alves, Vice President of Aviation and Maritime Health, MedAire

Paulo Magalhães Alves, MD, MSc, provides technical guidance and analysis for MedAire’s MedLink medical advisory service, as well as is a member of the MedAire Medical Advisory Board.

A popular presenter and requested speaker, Dr. Alves also authors papers and articles on medical topics affecting remote medicine based on trends in medicine and technology.

A cardiologist, Dr. Alves previously was the Medical Director for Varig Brazilian Airlines and was a member of the IATA Medical Advisory Group from 2002 to 2006.

Dr. Alves is a member of the International Academy of Aerospace Medicine, a fellow of the Aerospace Medical Association and a member of the American Telemedicine Association.

He is President-elect for the Airlines Medical Directors Association and past-president of the Brazilian Society of Aerospace Medicine.

In May 2010, AMDA awarded Dr. Alves the George J. Kidera Award for Outstanding Achievement in the Field of Aviation Medicine, and in May 2012, Dr. Alves was awarded the Boothby-Edwards Award for Outstanding Research and Clinical Practice in Aviation Medicine.

Dr Nomy Ahmed, Emirates
MBChB MAvMed MRCGP DOccMed DRCOG DFFP

Dr Nomy Ahmed (male) is a UK born and trained doctor completing his MBChB in 1994 He currently works as a specialist in Aviation Medicine; Aero-medical examiner and MRO for Emirates Airline medical clinic. He completed his Masters in Aviation Medicine in 2008 following his Diploma in Aviation Medicine previously from the University of Otago. Prior to joining Emirates he worked as a GP and Occupational physician in the UK for 5 years after completion of his Membership to the Royal College of GP’s and Diploma in Occupational Medicine.

He had given lectures at the Aviation and Space Medicine Association (AsMA) annual meetings in the USA, IATA Cabin Health Conferences and ICASM previously.

Dr. David Powell, Medical Officer, Air New Zealand, Otago University

David Powell has spent all of his medical career in the aviation sector. After 8 years with the Royal NZ Air Force, he was Chief Medical Officer with Air New Zealand from 1997-2009, qualifying as a specialist occupational physician in 2001. David now works for the airline part-time as an aviation medicine specialist, and continues to lead the Crew Alertness Study Group administering Air New Zealand’s Fatigue Risk Management System (FRMS). He also is a Senior Lecturer in Aviation Medicine with the University of Otago, and continues to fly, with commercial aeroplane and helicopter licences, an instrument rating and a helicopter instructor rating. David has published several papers related to fatigue in airline crews, and participated in various international working groups on fatigue. He was a consultant to ICAO developing a competency-based framework for training aviation medical examiners, and consults to a number of airlines in both FRMS and aviation medicine.

Dr Rose Ong, Head of Corporate Medical Department, Cathay Pacific Airways Ltd.

Dr. Ong is the Head of the Corporate Medical Department for Cathay Pacific Airways in Hong Kong, Hong Kong’s flag carrier, overseeing the aviation and occupational health units. The airline operates scheduled passenger and freighter services to more than 160 destinations in over 42 countries with a fleet of 135 wide-body aircraft. It also has a wholly owned subsidiary airline Dragonair, which operates to more than 30 destinations. The airline is a founding member of the OneWorld global alliance.

Dr. Ong is a member of the Aerospace Medical Association, International Academy of Aviation and Space Medicine, IATA Medical Advisory Group, Australasian Society of Aerospace Medicine and Vice President of Airline Medical Directors Association.

Dr. Ong is also an Executive Council Member of the Airline Medical Directors Association, an Associate Fellow of the Aerospace Medical Association, a Fellow of the American College of Occupational and Environmental Medicine and a Fellow of the American Academy of Family Physicians.

Dr. Ong has served as an Adjunct Assistant Professor in the School of Public Health and Primary Care at the Chinese University of Hong Kong since 2006.

Dr Christine de Vries, Medical Officer, KLM Health Services

I have been working for KLM since July 1994 as an occupational physician. First for Catering, Maintenance and Corporate Divisions, and from 1997 for flying divisions, for both cabin and cockpit crew. From that time on I was trained and authorized as an AME for American, European and Canadian Aviation Authorities, performing pilots medicals.

In 2003 I became member of the Advisory Board for the Dutch CAA. From 2010 I am Head of Aeromedical Affairs.

Dr. David Salisbury, Director Medicine, Transport Canada

Dr. David Salisbury was appointed the Director of Medicine, Civil Aviation, Transport Canada in May 2008.

Dave was born and raised in Ottawa. He enrolled in the Canadian Forces in 1975. Dr. Salisbury graduated from Queen’s University Medical School in 1978. After internship at McMaster University he was posted as the Base Medical Officer at CFB Portage la Prairie. In 1982 he was selected for the flight surgeon pilot program and commenced pilot training. He received his pilot wings in 1983 and stayed on at CFB Moose Jaw as the Base Surgeon where he was the pilot/physician in charge of the CF Motion Sickness treatment program and he was the flight surgeon for the Snowbirds. He obtained his Master’s in Occupational Health from UBC in 1987. In 1988 he attended the USAF Residency in Aerospace Medicine at USAF School of Aerospace Medicine, Brooks AFB, San Antonio TX and earned his USAF Senior Flight Surgeon Wings. He is Board certified in Aerospace Medicine by the American Board of Preventive Medicine and has his Royal College Fellowship in Community Medicine.

During his time in the military Dave spent time in Manitoba, Saskatchewan, British Columbia, Texas, Croatia and Ontario. His last position was as head of public health for the Canadian Forces at National Defence HQ in Ottawa. He had previously been Medical Advisor to the Chief of the Air Staff and Commanding Officer of the Canadian Forces Environmental Medicine Establishment. (CFEME)

Upon retirement from the CF in 2004, Dr. Salisbury joined Ottawa Public Health and in August 2005 he was named Medical Officer of Health of the City of Ottawa.

Dr. Fiona Rennie, Vice President Aviation and Occupational Medicine , Emirates Medical Services Dubai

Dr Fiona Rennie, Vice President of Aviation and Occupational Medicine Emirates based in Dubai. Worked for Emirates in Aviation Medicine for 7 years , prior to that civilian contractor with Royal Australian Navy for 7 years. Frequent presenter at Aviation Health Conference!

Michael Mikalakis, Team Leader, LGC Forensics

Studied at Nottingham, Warwick, and Kingston and ended up with a BSc, MSc, and a PGCE.

After a short stint teaching science to secondary students there was a change in direction landing a job with The Laboratory of the Government Chemist (now LGC) back in 1999. Over the years worked in the fields of drugs in animals (alive and deceased), drugs in humans (alive and deceased), and the evaluation of hydrocarbon fuels. Much of this time has been spent working in the forensic arena and primarily in the analysis and interpretation of drugs in humans (toxicology).

Fully trained in giving evidence to Courts and have contributed to different cases on a number of occasions. While working at LGC roles have included analyst, senior analyst, toxicologist, lead scientist, and laboratory manager. The last four years have been as the Team Leader for the Occupational Drug Testing (ODT), Toxicology, and Fuel Fraud teams with the role focussed on customer requirements.